Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Depsipeptide (FK228) as a Novel Histone Deacetylase Inhibitor: Mechanism of Action and Anticancer Activity

Author(s): Ewa Lech-Maranda, Ewa Robak, Anna Korycka and Tadeusz Robak

Volume 7, Issue 10, 2007

Page: [1062 - 1069] Pages: 8

DOI: 10.2174/138955707782110178

Price: $65

Abstract

Depsipeptide (FK228), a new histone deacetylase inhibitor, has been recently introduced into clinical trials. This agent shows interesting metabolic properties, novel mechanism of action, and is undergoing phase I-II clinical studies in hematopoietic malignancies and solid tumors. Mechanism of action, pharmacokinetics and anticancer activity of depsipeptide is the subject of this review.

Keywords: Epigenetic therapy, histone deacetylase inhibitors, depsipeptide (FK228), cutaneous T-cell lymphoma, solid tumors


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy